IBM's Anderon Finalizes $1B CHIPS Award, Quantum Wafers Enter Production
IBM sits 24% above its 52-week low of $199.19.
Summary
Anderon, an IBM company, finalized a $1 billion CHIPS and Science Act award with the U.S. Department of Commerce to accelerate R&D for its pure-play quantum foundry. The agreement converts the May letter of intent into a binding award, backed by an additional $1 billion investment from IBM. Anderon has also reached an operational milestone: first quantum wafers are now running through its 300mm manufacturing facility in Albany, NY. This strengthens IBM's quantum roadmap and domestic supply chain positioning. The news follows IBM's July guidance cut and 25% share plunge, offering a positive development in a strategically important segment.
At the time of this announcement, IBM was trading at $247.88 on NYSE in the Technology sector, with a market capitalization of approximately $234B. The 52-week trading range was $199.19 to $332.46. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.